JAN 13, 2021 2:45 PM PST

Antibody Can Target Dengue Viral Proteins

WRITTEN BY: Nouran Amin

Researchers have found an antibody that can stop the spread of the dengue virus—a mosquito-borne pathogen that infects 50 to 100 million people a year. Some of the symptoms of the virus includes fever, vomiting, muscle aches. It may lead to serious illness requiring long-term hospitalization and even in some cases fatal.

The dengue virus utilizes a particle protein called Non-Structural Protein 1 (NS1) that latches on the protective cells of organs and weakening the natural protective barrier. This allows virus to infect cells causing the rupture of blood vessels.

Learn more about the dengue virus:

However, the research shows that the antibody referred to as 2B7 will physically block the activity of NS1. It is effective against all four strains of the dengue virus.

"Flaviviruses infect hundreds of millions of people a year, and tens of thousands die from the associated diseases," said Argonne's Bob Fischetti, group leader with the X-ray Sciences Division and life sciences advisor to the APS director. "Protein structures determined at the APS have played a critical role in the development of drugs and vaccines for several diseases, and these new results are key to the development of a potentially effective treatment against flaviviruses."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
NOV 30, 2020
Microbiology
Common Antibiotic Could be Effective Zika Treatment
NOV 30, 2020
Common Antibiotic Could be Effective Zika Treatment
Zika virus cause a devastating epidemic in 2015, and led to the birth of hundreds of children that had congenital brain ...
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
JAN 19, 2021
Immunology
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
JAN 19, 2021
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
Milk, eggs, peanuts, tree nuts, wheat, soy, fish, and shellfish—these foods are among the most unwanted list for t ...
JAN 22, 2021
Drug Discovery & Development
Treating NF1: Investigational Drug Shows Positive Results
JAN 22, 2021
Treating NF1: Investigational Drug Shows Positive Results
From preclinical studies, researchers have found that an investigational drug called ‘cabozantinib’ can trea ...
JAN 24, 2021
Drug Discovery & Development
Finding New Cancer Drugs
JAN 24, 2021
Finding New Cancer Drugs
Cells in our body share the same genes. But how those genes are expressed can dictate the fate of a cell. For ...
Loading Comments...